Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.37 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | NQO1 | P15559 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9858819 | 0.88 | ALDH1A1 (0.41) | ADRA2AADRA2BADRA2CADRA1AADRA1D | |
| SCHEMBL2992858 | 0.82 | SLC6A4 (0.53) | TYRSLC6A4ADRA2AADRA2BADRA2C | |
| SCHEMBL28931321 | 0.82 | SLC6A4 (0.53) | TYRSLC6A4ADRA2AADRA2BADRA2C | |
| SCHEMBL7912238 | 0.81 | ALDH1A1 (0.39) | SLC6A4ALDH1A1KDM4EGAAHSD17B10 | |
| SCHEMBL21753859 | 0.81 | TYR (0.44) | TYRSLC6A4ALDH1A1UGT2B7HSD17B10 | |
| SCHEMBL3248268 | 0.80 | MTNR1A (0.49) | CYP1A2 | |
| SCHEMBL11739257 | 0.80 | CYP1A2 (0.43) | ALDH1A1KDM4EGAAUGT2B7HSD17B10 | |
| SCHEMBL29211313 | 0.79 | ALDH1A1 (0.38) | SLC6A4ALDH1A1KDM4EGAAHSD17B10 | |
| SCHEMBL6677010 | 0.77 | ALDH1A1 (0.43) | SLC6A4ALDH1A1KDM4EGAAHSD17B10 | |
| SCHEMBL22288169 | 0.77 | ALDH1A1 (0.40) | ADRA2AADRA2BADRA2CALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092924-A1 | NON-ENZYMATIC GLOW ASSAYS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-04-02 | — | — | US | claimed |
| US-20220011315-A1 | NON-ENZYMATIC GLOW ASSAYS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2022-01-13 | — | — | US | claimed |
| EP-3877753-A1 | NON-ENZYMATIC GLOW ASSAYS | University of Houston System (US) | 2021-09-15 | — | — | EP | claimed |
| US-20050118123-A1 | Use of chemiluminescence in cosmetics & chromatography | VAIDYA NITEEN A (US) | 2005-06-02 | — | — | US | claimed |
| US-20260092924-A1 | NON-ENZYMATIC GLOW ASSAYS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2026-04-02 | — | — | US | disclosed |
| EP-3877753-B1 | NON-ENZYMATIC GLOW ASSAYS | UNIV HOUSTON SYSTEM (US) | 2025-10-08 | — | — | EP | disclosed |
| CN-110036343-B | Water-soluble composition, pattern forming agent, method for producing cured product using same, and cured product | 株式会社ADEKA | 2023-06-13 | — | — | CN | disclosed |
| CN-115109059-A | Asymmetric diamino triazine substituted perylene bisimide and synthesis method thereof | 华南理工大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-110337454-B | Water-soluble composition, method for producing cured product thereof, and acylphosphinate | 株式会社ADEKA | 2022-04-12 | — | — | CN | disclosed |
| US-20220011315-A1 | NON-ENZYMATIC GLOW ASSAYS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2022-01-13 | — | — | US | disclosed |
| EP-3877753-A1 | NON-ENZYMATIC GLOW ASSAYS | University of Houston System (US) | 2021-09-15 | — | — | EP | disclosed |
| CN-109312135-B | Water-soluble composition and cured product comprising same | 株式会社ADEKA | 2021-07-06 | — | — | CN | disclosed |
| US-7081320-B2 | High energy density secondary battery for repeated use | CANON KABUSHIKI KAISHA (JP) | 2006-07-25 | — | — | US | disclosed |
| US-6395423-B1 | FILM COVERING OF ELECTRODE | CANON KABUSHIKI KAISHA (JP) | 2002-05-28 | — | — | US | disclosed |
| US-6391492-B1 | OXIDATION OF TITANIUM, VANADIUM, CHROMIUM, MANGANESE, IRON, COBALT, NICKEL OR COPPER BY REACTION TRANSITION METAL COMPOUND WITH WATER, ALCOHOL, OR HYDROXIDE; LITHIUM BATTERIES; DURABILITY | CANON KABUSHIKI KAISHA (JP) | 2002-05-21 | — | — | US | disclosed |
| US-20020031701-A1 | High energy density secondary battery for repeated use | KAWAKAMI SOICHIRO (JP) | 2002-03-14 | — | — | US | disclosed |
| EP-0600718-B1 | Secondary battery | CANON KK (JP) | 2000-04-26 | — | — | EP | disclosed |
| US-5824434-A | A POROUS MULTILAYER METAL OXIDE FILM SEPARATOR FOR INHIBITING THE DENDRITES GROWTH ON ELECTRODES; PREVENT SHORT CIRCUITS, DURABILITY, LONG CYCLE LIFE | CANON KABUSHIKI KAISHA (JP) | 1998-10-20 | — | — | US | disclosed |
| EP-0809314-A2 | Positive active material, method of manufacturing and secondary battery using the same | CANON KABUSHIKI KAISHA (JP) | 1997-11-26 | — | — | EP | disclosed |
| EP-0600718-A2 | Secondary battery | CANON KABUSHIKI KAISHA (JP) | 1994-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092924-A1 | NON-ENZYMATIC GLOW ASSAYS | LPO, HAO2, PPOX | TYR 88/4885SLC6A4 3271/4885ADRA2A 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.